COVID-19 host genetics initiative

The COVID-19 host genetics initiative brings together the human genetics community to generate, share, and analyze data to learn the genetic determinants of COVID-19 susceptibility, severity, and outcomes. Such discoveries could help to generate hypotheses for drug repurposing, identify individuals at unusually high or low risk, and contribute to global knowledge of the biology of SARS-CoV-2 infection and disease.

Helsinki’s Institute for Molecular Medicine Finland (FIMM) spearheaded the project which already has interest from partners worldwide, including: FIMM, Regeneron, Illumina, Helix, Erasmus MC, Gencove, Genomics Medicine Ireland (GMI), SciLifeLab. The UK Biobank, one of world’s largest with DNA data for 500,000 participants, also plans to add COVID-19 health data from participants to its data set.

The COVID-19 host genetics initiative is a bottom-up collaborative effort that has three main aims:

1. Provide an environment to foster the sharing of resources to facilitate COVID-19 host genetics research (e.g. protocols, questionnaires).

2. Organize analytical activities across studies to identify genetic determinants of COVID-19 susceptibility and severity.

3. Provide a platform to share the results from meta-analytical activities to benefit the broader scientific community.

At present there are more than 100 studies participating in the initiative and they have launched a portal to allow exploring studies, research questions and foster collaborations.

To read more about the initiative visit their website

10 views0 comments

This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium